UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

Clinical cancer research, 2021-04, Vol.27 (8), p.2139-2147

2021

Volltextzugriff (PDF)

Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial

European journal of cancer (1990), 2022-02, Vol.162, p.161-169

2022

Volltextzugriff (PDF)

Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma

British journal of cancer, 2020-09, Vol.123 (5), p.772-784

2020

Volltextzugriff (PDF)

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial

BMC cancer, 2021-11, Vol.21 (1), p.1180-1180, Article 1180

2021

Volltextzugriff (PDF)

Targeting ERBB2 mutations in solid tumors: biological and clinical implications

Journal of hematology and oncology, 2018-06, Vol.11 (1), p.86-86, Article 86

2018

Volltextzugriff (PDF)

New Topoisomerase I mutations are associated with resistance to camptothecin

Molecular cancer, 2011-05, Vol.10 (1), p.64-64, Article 64

2011

Volltextzugriff (PDF)

Clinical impact of extensive molecular profiling in advanced cancer patients

Journal of hematology and oncology, 2017-02, Vol.10 (1), p.45-45, Article 45

2017

Volltextzugriff (PDF)

The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II

Molecular pharmacology, 2012-07, Vol.82 (1), p.134-141

2012

Volltextzugriff (PDF)

Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity

Carcinogenesis (New York), 2012-05, Vol.33 (5), p.962-968

2012

Volltextzugriff (PDF)

Antitumor activity of semisynthetic derivatives of Aconitum alkaloids

Investigational new drugs, 2014-02, Vol.32 (1), p.60-67

2014

Volltextzugriff (PDF)

Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel

Biochemical pharmacology, 2008-01, Vol.75 (2), p.476-483

2008

Volltextzugriff (PDF)

Abstract 5716: Functional evidence for an immunosuppressive role of kynurenine in cancer patients

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5716-5716

2018

Volltextzugriff (PDF)

Ubiquitous and kidney-specific subunits of vacuolar H+-ATPase are differentially expressed during nephrogenesis

Journal of the American Society of Nephrology, 2005-11, Vol.16 (11), p.3235-46

2005

Volltextzugriff (PDF)

A functionalized heterobimetallic Tc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations

Dalton transactions : an international journal of inorganic chemistry, 2014-01, Vol.43 (2), p.439-45

2014

Volltextzugriff (PDF)

Abstract 2200: Relationship between cytochrome P450 1B1 (CYP1B1) and head and neck cancer cells proliferation, dissemination and chemosensitivity to anticancer drugs

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2200-2200

2013

Volltextzugriff (PDF)

PEMBROCABOSARC: Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS11586-TPS11586

2023

Volltextzugriff (PDF)

A Novel Voltage-dependent Chloride Current Activated by Extracellular Acidic pH in Cultured Rat Sertoli Cells

The Journal of biological chemistry, 2003-05, Vol.278 (21), p.19230-19236

2003

Volltextzugriff (PDF)

A functionalized heterobimetallic 99m Tc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations

Dalton transactions : an international journal of inorganic chemistry, 2014, Vol.43 (2), p.439-450

2014

Volltextzugriff (PDF)

Abstract 2531: Vescalagin, a polyphenolic ellagitanin specifically inhibiting the alpha isoform of human DNA topoisomerase II

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2531-2531

2011

Volltextzugriff (PDF)

CAIRE: A basket multicenter open-label phase 2 study evaluating the EZH2 inhibitor tazemetostat in combination with durvalumab in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2703-TPS2703

2022

Volltextzugriff (PDF)

Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma: Br J Cancer

British journal of cancer, 2020-09, Vol.123 (5), p.772-784

2020

Volltextzugriff (PDF)

Abstract 3519: The polyphenolic ellagitanin vescalagin is a specific inhibitor of the alpha isoform of human DNA topoisomerase II

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3519-3519

2010

Volltextzugriff (PDF)

Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel

Biochemical pharmacology, 2008-01, Vol.75 (2), p.476-483

2008

Volltextzugriff (PDF)

Chloride Channels and Endocytosis: New Insights from Dent’s Disease and ClC-5 Knockout Mice

Nephron. Physiology, 2005, Vol.99 (3), p.p69-p73

2005

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial

Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial

Targeting ERBB2 mutations in solid tumors: biological and clinical implications

New Topoisomerase I mutations are associated with resistance to camptothecin

Clinical impact of extensive molecular profiling in advanced cancer patients

The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II

Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity

Antitumor activity of semisynthetic derivatives of Aconitum alkaloids

Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel

Abstract 5716: Functional evidence for an immunosuppressive role of kynurenine in cancer patients

Ubiquitous and kidney-specific subunits of vacuolar H+-ATPase are differentially expressed during nephrogenesis

Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan

A functionalized heterobimetallic Tc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations

Abstract 2200: Relationship between cytochrome P450 1B1 (CYP1B1) and head and neck cancer cells proliferation, dissemination and chemosensitivity to anticancer drugs

PEMBROCABOSARC: Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas

A Novel Voltage-dependent Chloride Current Activated by Extracellular Acidic pH in Cultured Rat Sertoli Cells

A functionalized heterobimetallic 99m Tc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations

Abstract 2531: Vescalagin, a polyphenolic ellagitanin specifically inhibiting the alpha isoform of human DNA topoisomerase II

CAIRE: A basket multicenter open-label phase 2 study evaluating the EZH2 inhibitor tazemetostat in combination with durvalumab in patients with advanced solid tumors

Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma: Br J Cancer

Abstract 3519: The polyphenolic ellagitanin vescalagin is a specific inhibitor of the alpha isoform of human DNA topoisomerase II

Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel

Chloride Channels and Endocytosis: New Insights from Dent’s Disease and ClC-5 Knockout Mice

Suchergebnisse filtern